HUMANOG INZULINA in English translation

• human insulin

Examples of using Humanog inzulina in Croatian and their translations into English

Insulin Human Winthrop Basal može se miješati sa svim pripravcima humanog inzulina, OSIM s onima koji su posebno namijenjeni za primjenu u inzulinskim pumpama.
Insulin Human Winthrop Basal may be mixed with all insulin human preparations, EXCEPT those specially designed for use in insulin pumps.

Insulin Human Winthrop Basal se ne smije miješati s formulacijama humanog inzulina koje su posebno namijenjene za primjenu u inzulinskim pumpama.
Insulin Human Winthrop Basal must not be mixed with insulin human formulations designed specifically for use in insulin pumps.

Nemojte miješati inzulin s drugim lijekovima, osim s pripravcima humanog inzulina koji su navedeni u nastavku.
Do not mix insulin with any other medicine except with insulin human preparations as detailed below.

molekule humanog inzulina; niti jedan od metabolita nastalih nakon cijepanja nije aktivan.
sites on the human insulin molecule have been proposed; none of the metabolites formed following the cleavage are active.

Jedna napunjena brizgalica sadrži 300 internacionalnih jedinica humanog inzulina u 3 ml otopine za injekciju.
Each pre-filled pen contains 300 international units of human insulin in 3 ml solution for injection.

Degludek inzulin veže se specifično na receptore humanog inzulina i ima iste farmakološke učinke kao i humani inzulin..
Insulin degludec binds specifically to the human insulin receptor and results in the same pharmacological effects as human insulin..

aspart inzulina slična je razgradnji humanog inzulina; svi nastali metaboliti su neaktivni.
insulin aspart is similar to that of human insulin; all metabolites formed are inactive.

Jedna(1) jedinica(U) degludek inzulina odgovara 1 internacionalnoj jedinici(IU) humanog inzulina, 1 jedinici glargin inzulina
One(1) unit(U) of insulin degludec corresponds to 1 international unit(IU) of human insulin, 1 unit of insulin glargine

Relativne razlike u farmakokinetičkim svojstvima aspart inzulina i otopine humanog inzulina u starijih bolesnika(65-83 godine,
The relative differences in pharmacokinetic properties between insulin aspart and soluble human insulin in elderly patients(65-83 years,

odnosno otopine humanog inzulina primijenjene 30 minuta prije obroka(isprekidana linija)
or soluble human insulin administered 30 minutes before a meal(hatched curve)

U bolesnika sa šećernom bolešću tipa 2 i različitim stupnjevima bubrežne funkcije farmakokinetičke razlike između inzulina lispro i topljivog humanog inzulina općenito su održane
In patients with type 2 diabetes over a wide range of renal function the pharmacokinetic differences between insulin lispro and soluble human insulin were generally maintained

Jedna(1) jedinica(U) lijeka Ryzodeg odgovara 1 internacionalnoj jedinici(IU) humanog inzulina, 1 jedinici glargin inzulina,
One(1) unit(U) of Ryzodeg corresponds to 1 international unit(IU) of human insulin, 1 unit of insulin glargine,

izloženim humanom inzulinu nakon stavljanja lijeka u promet ukazuje na to da primjena humanog inzulina ne djeluje štetno na trudnoću.
300 pregnancy outcomes reported) exposed to marketed insulin human indicates no safety issues in use of insulin human in pregnancy.

analog humanog inzulina) i/ili načinu proizvodnje(rekombinantna DNK naspram inzulina životinjskog podrijetla)
human insulin analogue), and/or method of manufacture(recombinant DNA versus animal-source insulin)

infuzijski sustavi s lijekom Actrapid u koncentraciji od 0, 05 internacionalnih jedinica/ ml do 1, 0 internacionalnih jedinica/ ml humanog inzulina u infuzijskoj otopini 0, 9% natrijeva klorida,
infusion systems with Actrapid at concentrations from 0.05 international unit/ml to 1.0 international unit/ml human insulin in the infusion fluids 0.9% sodium chloride,

primjena drugog humanog inzulina, čija je formulacija slična onoj lijeka Insuman, kroz kateter pričvršćen za ovojnicu jetre pokazala je da intraperitonejska primjena visoke koncentracije inzulina lokalno u ovojnicu jetre može inducirati reverzibilnu fokalnu steatozu jetre.
conducted in diabetic rats, administration of another human insulin with a formulation similar to Insuman via a catheter fixed to the liver capsule showed that intraperitoneal administration of high local insulin concentration at the liver capsule may induce reversible focal hepatic steatosis.

Actraphane je humani inzulin s brzim i dugotrajnim djelovanjem.
Actraphane is human insulin with both a fast-acting and a long-acting effect.

Humani inzulin proizveden je tehnologijom rekombinantne DNK na bakteriji Escherichia coli.
Human insulin is produced by recombinant DNA technology in Escherichia coli.

Protaphane je humani inzulin s postupnim početkom
Protaphane is a human insulin with a gradual onset

Actraphane 30 100 internacionalnih jedinica/ml suspenzija za injekciju u bočici humani inzulin.
Actraphane 30 100 international units/ml suspension for injection in vial human insulin.